The Daily Target 2X Long MRNA ETF (MRNX) seeks to provide 200% daily leveraged exposure to the performance of Moderna, Inc. (MRNA) through the use of swap agreements, short-dated listed call options, and collateral in interest-bearing securities such as US government bonds and corporate debt. This report evaluates MRNX against Shariah compliance standards, including financial ratios, business activities, ESG factors, and index inclusions. Due to its reliance on speculative derivatives and riba-based instruments, MRNX is deemed non-compliant across major Shariah authorities and indices. Numerical financial ratios appear favorable due to the ETF structure lacking traditional debt, but qualitative business model flaws dominate the assessment. Investors are advised to consider Shariah-compliant alternatives in the Asset Management sector for ethical investing.